» Articles » PMID: 22344779

[(Cp-R)M(CO)3] (M=Re or 99mTc) Arylsulfonamide, Arylsulfamide, and Arylsulfamate Conjugates for Selective Targeting of Human Carbonic Anhydrase IX

Overview
Specialty Chemistry
Date 2012 Feb 21
PMID 22344779
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Enhanced receptor selectivity: carbonic anhydrase inhibitors are relevant for both cancer diagnosis and therapy. Combining non-radioactive Re compounds with their radioactive (99m)Tc homologs enables the use of identical molecules for therapy and imaging (theragnostic). The syntheses and in vitro evaluation of [(Cp-R)M(CO)(3)] (Cp=cyclopentadienyl, M=Re, (99m)Tc) with R being a highly potent carbonic-anhydrase-targeting vector is reported.

Citing Articles

Carbon Monoxide Release from Aryl-Propargyl Dicobalt(0)Hexacarbonyl Derivatives: A Computational and Experimental Study.

Paciotti R, Coletti C, Berrino E, Arrighi F, Maccelli A, Lasalvia A Int J Mol Sci. 2024; 25(21).

PMID: 39519196 PMC: 11546923. DOI: 10.3390/ijms252111644.


MetalDock: An Open Access Docking Tool for Easy and Reproducible Docking of Metal Complexes.

Hakkennes M, Buda F, Bonnet S J Chem Inf Model. 2023; 63(24):7816-7825.

PMID: 38048559 PMC: 10751784. DOI: 10.1021/acs.jcim.3c01582.


Ru(ii)/Os(ii)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours.

Wang Y, Mesdom P, Purkait K, Saubamea B, Burckel P, Arnoux P Chem Sci. 2023; 14(42):11749-11760.

PMID: 37920359 PMC: 10619633. DOI: 10.1039/d3sc03932c.


Exploring the Anticancer Activity of Tamoxifen-Based Metal Complexes Targeting Mitochondria.

Scalcon V, Bonsignore R, Aupic J, Thomas S, Folda A, Heidecker A J Med Chem. 2023; 66(14):9823-9841.

PMID: 37410388 PMC: 10388301. DOI: 10.1021/acs.jmedchem.3c00617.


Bifunctional chelators for radiorhenium: past, present and future outlook.

Melis D, Burgoyne A, Ooms M, Gasser G RSC Med Chem. 2022; 13(3):217-245.

PMID: 35434629 PMC: 8942221. DOI: 10.1039/d1md00364j.